PetVivo Reveals Hydrogel Osteoarthritis Study Results
Research at a Madison facility shows mobility improvements in rhesus macaques treated with a collagen-elastin hydrogel.
Updated on Oct. 15, 2026 in Veterinary Medicine
Live Poll
Is medical research on animals to treat joint conditions justified by the potential health benefits?
PetVivo has released two research abstracts evaluating the use of its Spryng with OsteoCushion Technology to treat osteoarthritis in rhesus macaques. The study, conducted in collaboration with the Wisconsin National Primate Research Center in Madison, tested the hydrogel's efficacy and tissue response.
Why it matters
This research aims to determine the effectiveness of intra-articular hydrogel injections for managing naturally occurring osteoarthritis. The findings could influence future veterinary treatment options for joint disease.
The mobility study involved 18 rhesus macaques, while the tissue response study utilized four subjects. Histologic evaluation found hydrogel integration into the synovial membrane by day 11, with material remaining identifiable through day 28.
The players
PetVivo
This is a biomedical company that focuses on developing and commercializing products for the treatment of joint diseases in animals.
Wisconsin National Primate Research Center
Part of the University of Wisconsin-Madison, this facility conducts research on primate biology and disease to improve both animal and human health.
The details
The research team administered the hydrogel via intra-articular injection and tracked mobility through various metrics, including walking speed and goniometry. Histologic analysis showed minimal inflammatory cellular infiltrates associated with the material, which appeared reduced by day 54.
Timeline
October 21-24, 2026: APV Workshop in Houston, Texas.
October 23, 2026: Consecutive presentations of abstracts at the APV Workshop.
October 25-29, 2026: AALAS National Meeting in Houston, Texas.
October 28, 2026: Platform presentation at the AALAS National Meeting.
November 14-17, 2026: ACVP Annual Meeting in Indianapolis, Indiana.
Culture Shift
This study reflects a growing trend in veterinary medicine toward non-surgical, regenerative interventions for chronic conditions like osteoarthritis. By leveraging primate models, researchers aim to bridge the gap between initial clinical trials and broader veterinary application.
As this study was conducted at the Wisconsin National Primate Research Center in Madison, local pet owners and veterinary professionals may see increased dialogue surrounding regenerative joint therapies. These findings highlight ongoing efforts in the city to refine non-surgical treatments for joint health.
The takeaway
The study suggests that collagen-elastin hydrogels may be a viable long-term strategy for managing osteoarthritis in animals. Further data will be essential to fully characterize the material's degradation and long-term functional benefits.
What happens next
The research team plans to present their findings at the APV Workshop on October 23, 2026, the AALAS National Meeting on October 28, 2026, and the ACVP Annual Meeting in mid-November 2026.
Further reading
For additional context on current clinical advancements, explore the Veterinary Medicine section.
Source note: This article includes information reported by The Manila times.
Live Poll
Is medical research on animals to treat joint conditions justified by the potential health benefits?
